Return
Long-term efficacy of cognitive behavioural therapy for insomnia (CBT-I) on depressive symptoms: A systematic review and meta-analysis of randomised controlled trials
V
C
C
A
DOI:10.1016/j.smrv.2026.102339.png)
Abstract
En 中文
Depressive symptoms are common in individuals with persistent insomnia. Previous meta-analyses of randomised controlled trials (RCTs) showed that cognitive behavioural therapy for insomnia (CBT-I) can reduce depressive symptoms at post-treatment. However, the long-term maintenance of these improvements has never been systematically examined. To fill-in this gap, we conducted a systematic review and meta-analysis of the long-term (≥3 months) effects of CBT-I on depressive symptoms. The review was registered in PROSPERO (CRD420251146061). Only RCTs in adults with insomnia were considered. Pubmed, Scopus, Psycinfo, CINAHL, and Medline were searched up to 12 September 2025 with no predefined time constraints. From 5359 records initially retrieved, we included 53 articles reporting on 13608 individuals. After outliers removal, random effects meta-analysis showed that CBT-I was superior to control conditions in reducing depressive symptoms at 3 [k=29, d= -.35, [95% CI: -.49 to -.21], p<.001], 6 [k=29, d= -.32, [95% CI: -.59 to -.05], p=.018], and 12 [k=10, d= -.25, [95% CI: -.39 to -.12], p<.001] months follow-ups. Results demonstrate that the effects of CBT-I on depressive symptoms are sustained throughout the year following treatment, although effects may decline over time.
Keywords:
sleep
psychopathology
mental disorders
mood
psychotherapy
Journal
IF:
9.7
Papers:
1.9K
Citations:
1.5W
